topical testosterone

DRUG3 trials

Sponsors

National Institute on Aging (NIA), Repros Therapeutics Inc., VA Office of Research and Development

Conditions

FrailtyMuscle WeaknessProstate CancerSarcopeniaSecondary Hypogonadism

Phase 2

HORMA: Hormonal Regulators of Muscle and Metabolism in Aging

CompletedNCT00183040

National Institute on Aging (NIA)Frailty, Muscle Weakness, Sarcopenia

Start: 2002-09-30End: 2007-02-28Target: 108Updated: 2009-06-02

Normalization of Morning Testosterone Levels in Men With Secondary Hypogonadism

CompletedNCT01270841

Repros Therapeutics Inc.Secondary Hypogonadism

Start: 2011-01-31End: 2011-12-31Updated: 2014-07-28

Randomized Phase II Trial of Targeted Radiation With no Castration for Mcrpc

RecruitingNCT06084338

VA Office of Research and DevelopmentProstate Cancer

Start: 2023-12-14End: 2028-12-31Target: 60Updated: 2025-12-31

Related Papers

Enclomiphene citrate stimulates testosterone production while preventing oligospermia: a randomized phase II clinical trial comparing topical testosterone.

2014-07-1747 citations

Whole-body and muscle protein metabolism are not affected by acute deviations from habitual protein intake in older men: the Hormonal Regulators of Muscle and Metabolism in Aging (HORMA) Study.

2011-05-043 citations